Zhejiang Dayang Biotech Group Co., Ltd. logo

Zhejiang Dayang Biotech Group Co., Ltd. (003017)

Market Closed
11 Aug, 06:57
XSHE XSHE
¥
21. 83
-0.26
-1.177%
¥
2.51B Market Cap
26.1 P/E Ratio
0.6% Div Yield
1.34M Volume
0 Eps
¥ 22.09
Previous Close
Add Transaction
Day Range
21.81 22.14
Year Range
18.82 31.66
Want to track 003017 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

003017 closed today lower at ¥21.83, a decrease of -1.177% from yesterday's close, completing a monthly decrease of -4.5892% or -¥1.05. Over the past 12 months, 003017 stock lost -30.0545%.
003017 pays dividends to its shareholders, with the most recent payment made on Jun 26, 2026. The next estimated payment will be in In 4 months on Dec 26, 2026 for a total of ¥0.3.
The last earnings report, released on May 21, 2025, exceeded the consensus estimates by 0.3535%. On average, the company has surpassed earnings expectations by 0.2818%, based on the last three reports.
Zhejiang Dayang Biotech Group Co., Ltd. has completed 2 stock splits, with the recent split occurring on Jun 26, 2026.
The company's stock is traded on one exchange.

003017 Chart

People also search for

Lucky Harvest Co., Ltd.
¥ 31.58
-1.6506%
Jiangsu Zhengdan Chemical Co., Ltd.
¥ 14.88
-1.1952%
Beijing Lier High-Temperature Materials Co. Ltd.
¥ 7.5
-1.0554%
Guangdong Haomei New Materials Co., Ltd.
¥ 21.19
-1.7161%
North Chemical Industries Co., Ltd.
¥ 22.47
+9.9853%

Zhejiang Dayang Biotech Group Co., Ltd. (003017) FAQ

What is the stock price today?

The current price is ¥21.83.

On which exchange is it traded?

Zhejiang Dayang Biotech Group Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 003017.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.6%.

What is its market cap?

As of today, the market cap is 2.51B.

Has Zhejiang Dayang Biotech Group Co., Ltd. ever had a stock split?

Zhejiang Dayang Biotech Group Co., Ltd. had 2 splits and the recent split was on Jun 26, 2026.

Zhejiang Dayang Biotech Group Co., Ltd. Profile

Chemicals Industry
Materials Sector
Ms. Xujun Chen CEO
XSHE Exchange
CNE100004736 ISIN
CN Country
797 Employees
26 Jun 2026 Last Dividend
26 Jun 2026 Last Split
- IPO Date

Overview

Zhe Jiang Dayang Biotech Group Co., Ltd. is a prominent entity in the chemical manufacturing industry, focusing on the production of chemical raw materials for various applications globally. Founded in 1976 and rooted in Jiande, China, the company has built a reputation for its extensive range of high-quality inorganic chemicals and fine chemical products, alongside its contributions to veterinary medicine through active pharmaceutical ingredients (APIs) and drug premixes. With its extensive product range, Zhe Jiang Dayang Biotech Group Co., Ltd. serves a diverse clientele across the food, agriculture, industrial, and veterinary sectors, marking its presence both domestically and internationally.

Products and Services

  • Inorganic Chemicals:

    Zhe Jiang Dayang offers a variety of essential inorganic chemicals, catering to different industries. Key products include food additive potassium carbonate and potassium bicarbonate, which are widely used in food processing. The company also supplies food and feed grade potassium chloride, along with agricultural and industrial grade ammonium chloride, highlighting its ability to meet diverse market needs.

  • Fine Chemical Products:

    The company's portfolio also includes fine chemicals such as 2-chloro-6-fiuorobenzaldehyde and 2-chloro-6-fluorobenzyl chloride, key intermediates in organic synthesis and pharmaceutical manufacturing. Anisole products further showcase Zhe Jiang Dayang's capabilities in producing specialized compounds for various industrial applications.

  • Veterinary APIs:

    Zhe Jiang Dayang extends its chemical expertise to the veterinary sector, offering active pharmaceutical ingredients like amprolium HCL. This product emphasizes the company's contribution to animal health by providing essential components for manufacturing veterinary medicines.

  • Veterinary Drug Premixes:

    In addition to APIs, the company also manufactures veterinary drug premixes, including anisole and enramycin premixes. These premixes simplify the process of administering precise doses of medicine to animals, thereby supporting efficient and effective animal healthcare.

Contact Information

Address: No. 22 Chaoyang Road, Jiande, China, 311616
Phone: 86 57 1641 56812